Evidence has steadily accumulated over the past 2 decades indicating, importantly, that oral conditions are related to systemic health and well-being. Biologically plausible mechanisms have been proposed to explain how oral infection and inflammation may be risk factors for several systemic health outcomes. There has been a relative paucity of experimental research in humans, however, to test whether or not treatment of oral disease leads to improved systemic health. To date, most of the evidence on oral-systemic relationships has come from observational studies which can only be viewed, at best, as 'hypothesis-generating' and not as 'hypothesis-testing.' This systematic review identified a total of nine studies (485 patients in all) that were controlled trials and could be included in the meta-analysis. Although their meta-analysis indicated that periodontal treatment was effective in reducing HbA1c levels (eg, SMD in HbA1c was 0.46; 95% CI, 0.11-0.82), the authors themselves express caution regarding the statistically significant, and clinically significant, finding. After conducting a sensitivity analysis, they discovered that exclusion of a single study, a non-RCT, 3 decreased the overall SMD to a nonsignificant value of 0.27 (95% CI, −0.01-0.60). Thus, the most appropriate conclusion that can be drawn from this analysis is that we still lack conclusive evidence to recommend periodontal treatment as an effective means by which to reduce HbA1c levels in adult diabetics. Darré and coworkers note that a RCT with sufficient statistical power would be an important next step, and their post-hoc calculation showed that a minimum sample size of 150 participants would be necessary for such future RCT.
